Related references
Note: Only part of the references are listed.CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury
Nobuyuki Tamaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocelluar carcinoma after curative hepatectomy
S. Tanaka et al.
BRITISH JOURNAL OF SURGERY (2008)
Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C
Julie R. Jonsson et al.
HEPATOLOGY (2008)
Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma
Yanting Qi et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Inhibition of jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma
Neil D. Gross et al.
CLINICAL CANCER RESEARCH (2007)
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma
Koichi Matsuzaki et al.
HEPATOLOGY (2007)
Reversible smad-dependent signaling between tumor suppression and oncogenesis
Go Sekimoto et al.
CANCER RESEARCH (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity
Daniele Taras et al.
JOURNAL OF HEPATOLOGY (2007)
The JNK signal transduction pathway
Claire R. Weston et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: A randomized trial
Kiyoshi Hasegawa et al.
HEPATOLOGY (2006)
Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection - An analysis of 610 patients over 16 years old
Kojiro Taura et al.
ANNALS OF SURGERY (2006)
High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine
Masaharu Tada et al.
JOURNAL OF GENE MEDICINE (2006)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TGFβ:: the molecular Jekyll and Hyde of cancer
Brian Bierie et al.
NATURE REVIEWS CANCER (2006)
Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials
P. M. Lopez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase
K Yoshimura et al.
NATURE MEDICINE (2005)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine
L Fiume et al.
JOURNAL OF HEPATOLOGY (2005)
Inhibition of c-jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M CO cycle arrest
C Kuntzen et al.
CANCER RESEARCH (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer et al.
HEPATOLOGY (2005)
TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions
S Mori et al.
ONCOGENE (2004)
c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line
Y Sugioka et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tumour necrosis factor α:: a potential target for the therapy of solid tumours
PW Szlosarek et al.
LANCET ONCOLOGY (2003)
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration
RF Schwabe et al.
HEPATOLOGY (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53
R Eferl et al.
CELL (2003)
Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective
RTP Poon et al.
ANNALS OF SURGERY (2002)
TGF-β signaling:: positive and negative effects on tumorigenesis
LM Wakefield et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity
MF Donato et al.
HEPATOLOGY (2001)
Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years
RTP Poon et al.
ANNALS OF SURGERY (2001)
AP-1 in cell proliferation and survival
E Shaulian et al.
ONCOGENE (2001)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Share Paper
